SHC Enzyme Variants for Homofarnesol-to-Ambrox Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing (−)-Ambrox and Ambra oxide are inefficient and lack improved methods for cyclizing other substrates to form compounds useful in fragrances.
Innovation Solution
Development of SHC/HAC enzyme variants with specific amino acid alterations, such as M132R, A224V, and 1432T, to enhance the enzymatic conversion of (3E,7E)-homofarnesol to (−)-Ambrox and E,E-bishomofarnesol to Ambra oxide, improving conversion rates and selectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type SHC enzymes are used for enzymatic conversion, then the process can be carried out with simple enzyme sources, but the conversion rates and productivity are insufficient
Solution Approach 1:
The patent applies parameter changes by modifying specific amino acid positions (132, 224, 432, and 557) in the SHC enzyme sequence to create variants with improved catalytic activity. The M132R, A224V, and I432T mutations specifically enhance conversion of (3E,7E)-homofarnesol to (−)-Ambrox, while A557T mutation improves conversion of E,E-bishomofarnesol to Ambra oxide, directly increasing productivity without requiring complex multi-enzyme systems
Solution Approach 2:
The patent implements local quality by introducing site-specific amino acid substitutions at key positions in the enzyme's active site or substrate-binding region. These localized changes (M132R, A224V, I432T, A557T) create enzymes with enhanced specificity and activity for particular substrates, improving conversion rates while maintaining overall enzyme structure simplicity
2Manufacturing precision
If existing SHC enzymes are used, then the method can be implemented with current technology, but the selectivity and efficiency for specific substrates are limited
Solution Approach 1:
The patent uses parameter changes through targeted amino acid substitutions to enhance substrate selectivity. The M132R and A224V mutations improve selectivity for (3E,7E)-homofarnesol, while the A557T mutation specifically enhances acceptance of E,E-bishomofarnesol substrate, allowing precise control over product specificity without complicating the manufacturing process
Solution Approach 2:
The patent applies local quality by modifying specific residues (132, 224, 432, 557) that are critical for substrate recognition and binding. These localized changes create enzymes with tailored selectivity profiles for different homofarnesol isomers, enabling precise manufacturing of desired fragrance compounds while maintaining ease of production through single-enzyme catalysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SHC/HAC enzyme variants demonstrate enhanced conversion rates and selectivity, enabling efficient production of (−)-Ambrox and Ambra oxide for use in fragrances and cosmetics, with improved productivity and substrate cyclization capabilities.
Implementation Method 1
enzymatically converting (3E,7E)-homofarnesol (EEH) or a mixture of isomers of homofarnesol comprising EEH to (−)-Ambrox or a mixture comprising (−)-Ambrox using a SHC/HAC enzyme variant
Implementation Method 2
enzymatically converting E,E-bishomofarnesol to Ambra oxide using a SHC/HAC enzyme variant
Data Source
AI summary
Squalene Hopene Cyclase (SHC) enzymes and variants thereof and their uses for making (−)-Ambrox from homofarnesol and Ambra oxide from bishomofarnesol.